Tags

Type your tag names separated by a space and hit enter

Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
Med Microbiol Immunol. 2002 Dec; 191(3-4):161-3.MM

Abstract

The neuraminidase inhibitors signifies a breakthrough in the treatment of influenza. We compared the outcomes of influenza in 56 patients treated with zanamivir or oseltamivir to a group of 52 influenza patients from the time before these drugs were available. The duration of illness was reduced by 45%, the severity of symptoms by 40% and the administration of antibiotics by 32%. The data from this small group of patients of our ambulatory practice correspond to the results of large randomized placebo-controlled double-blind studies on zanamivir and oseltamivir. Our clinical observations and painful experiences have taught us to take every case of suspected influenza seriously. Since considerable influenza-related complications are common even in otherwise healthy individuals, patients should immediately consult their doctor when an illness with sudden onset of fever and cough or another respiratory symptom occur.

Authors+Show Affiliations

Practice for Internal Medicine, Gastroenterology and Nephrology, Stievestrasse 5, 80638 Munich, Germany. Profvogel@t-online.de

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

12458352

Citation

Vogel, Georg E.. "Neuraminidase Inhibitors in the Management of Influenza--experience of an Outpatient Practice." Medical Microbiology and Immunology, vol. 191, no. 3-4, 2002, pp. 161-3.
Vogel GE. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Med Microbiol Immunol. 2002;191(3-4):161-3.
Vogel, G. E. (2002). Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Medical Microbiology and Immunology, 191(3-4), 161-3.
Vogel GE. Neuraminidase Inhibitors in the Management of Influenza--experience of an Outpatient Practice. Med Microbiol Immunol. 2002;191(3-4):161-3. PubMed PMID: 12458352.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. A1 - Vogel,Georg E, Y1 - 2002/10/25/ PY - 2002/07/12/received PY - 2002/11/30/pubmed PY - 2003/4/4/medline PY - 2002/11/30/entrez SP - 161 EP - 3 JF - Medical microbiology and immunology JO - Med. Microbiol. Immunol. VL - 191 IS - 3-4 N2 - The neuraminidase inhibitors signifies a breakthrough in the treatment of influenza. We compared the outcomes of influenza in 56 patients treated with zanamivir or oseltamivir to a group of 52 influenza patients from the time before these drugs were available. The duration of illness was reduced by 45%, the severity of symptoms by 40% and the administration of antibiotics by 32%. The data from this small group of patients of our ambulatory practice correspond to the results of large randomized placebo-controlled double-blind studies on zanamivir and oseltamivir. Our clinical observations and painful experiences have taught us to take every case of suspected influenza seriously. Since considerable influenza-related complications are common even in otherwise healthy individuals, patients should immediately consult their doctor when an illness with sudden onset of fever and cough or another respiratory symptom occur. SN - 0300-8584 UR - https://www.unboundmedicine.com/medline/citation/12458352/Neuraminidase_inhibitors_in_the_management_of_influenza__experience_of_an_outpatient_practice_ L2 - https://dx.doi.org/10.1007/s00430-002-0138-x DB - PRIME DP - Unbound Medicine ER -